The Life Sciences Center of Vilnius University (www.gmc.vu.lt/en/) is a partner institution of the European Molecular Biology Laboratory (www.embl.org) for genome editing technologies established in September 2020 with the aim to advance scientific understanding of the biology and mechanisms of CRISPR as well as other antiviral defense systems. Partnership is based on the scientific and technological potential of the VU LSC in the targeted genome modification. Prof. Virginijus Šikšnys of VU LSC is one of the pioneers in the breakthrough CRISPR gene editing technology, who did much of the early work in characterizing the molecular machinery involved in CRISPR-Cas function.
We are an institution of world-class research and study with outstanding people, a very collegial working environment and excellent up-to-date infrastructure.
The Life Sciences Center (VU LSC) is a faculty level operational unit of Vilnius University (VU, which is a major public research and higher education institution in Lithuania). VU LSC conducts scientific research, studies and technological development in disciplines including biochemistry, molecular biology, genetics, neurobiology, molecular medicine, biotechnology, cell and structural biology and other related sciences. The Center is home to 250 PhD degree researchers and around 1 000 undergraduate and postgraduate students. Integration of studies and research provides an incoming stream of young talents.